About Us

Jennifer Lieberman

Senior VP and General Counsel

Ms. Lieberman has over 20 years of healthcare law experience; her background and expertise is in transactional and regulatory healthcare and corporate matters. She has extensive experience in Clinical Laboratory, Pharmaceutical Healthcare, FDA, Federal Stark and Anti-Kickback Law compliance, HIPAA/HITECH compliance, Medicare/Medicaid reimbursement and enrollment, certificate of need and state licensing, state health care/professional regulatory compliance, payor/PBM contracting, M&A and commercial transactions in the medical, pharmaceutical, clinical toxicology laboratory, pharmacy, and healthcare industries. She provides regulatory advice and legal representation before regulatory bodies, including the HHS Office of Inspector General, HHS Office for Civil Rights, Board of Medicine and Board of Pharmacy (multi-state), Federal Trade Commission, Federal Food and Drug Administration and Drug Enforcement Administration relating to pharmacy/outsourcing operations.

Prior to joining Precision Diagnostics, she served for almost a decade as General Counsel to a national healthcare company and played a vital role in the growth of the company from its infancy to sale to a private equity consortium. During her tenure, Ms. Lieberman implemented various medical ancillary services, including CLIA laboratories, physical therapy facilities, pharmacies, durable medical equipment, and research facilities. Previous to her in-house counsel positions, she served as an associate attorney in the healthcare division and corporate securities department of the national law firm, Fox, Rothschild, O’Brien and Frankel, LLP. As a member of the Precision legal department, she continues her advisory role on federal and state fraud and abuse issues, including anti-kickback and self-referral laws, OIG guidance and advisory opinions, Medicare/Medicaid billing and reimbursement, contracting, TCPA and HIPAA, as well as, counsel on the implementation of new and innovative healthcare business lines to contribute to the revenue growth of the company.

She speaks nationally on regulatory issues involving the healthcare regulatory landscape, providing consulting to national pharmaceutical and toxicology facilities and closely assisting regulatory and legislative bodies in drafting healthcare rules and legislation.

Darrell Taylor, JD, BSMT (ASCP)

Chief Compliance Officer & Associate General Counsel

Mr. Taylor brings extensive industry experience and subject matter expertise to Precision Diagnostics, with almost 20 years of legal experience focusing on corporate and transactional, regulatory, and compliance matters in the healthcare and biopharmaceutical space. Prior to attending law school, Darrell built a strong healthcare foundation serving in leadership positions for 15 years in clinical laboratory operations with Lab Corp of America and various hospitals developing and implementing regulatory compliance programs. Darrell also is a veteran of the 1st Cavalry Division, U.S. Army.

Prior to joining Precision Diagnostics, Darrell served in several roles of increasing responsibility at global and start-up biopharmaceutical companies where he led a team of attorneys managing a portfolio including branded pharmaceuticals having annual revenues over $7B and providing substantive advice concerning legal, regulatory and compliance issues, including FDA regulations, False Claims Act, Anti-Kickback Statute, OIG guidance, PhRMA Code, HIPAA and the Sunshine Act, in connection with product labeling, promotional activities, marketing strategies, and interactions with healthcare professionals from product development thru FDA approval and launch.

Previous to his in-house counsel positions, Darrell honed his skills as an attorney with the global law firm, DLA Piper, serving healthcare companies, pharmacies, private equity, venture capital, institutional investors and providers by assisting them with navigating opportunities in this highly-complex, heavily-regulated, and ever-changing industry.

Darrell joined Precision Diagnostics in July 2020 as Healthcare Regulatory Counsel. In February 2021, he was promoted to Chief Compliance Officer & Associate General Counsel overseeing Precision’s Compliance Program and working across the organization on business opportunities from a legal and compliance perspective.

Darrell earned his J.D. from the University of Notre Dame Law School and his B.S.M.T., with high honors, at The University of Texas Medical Branch. When not working, he enjoys hiking, traveling, and spending time with his family and two dogs.

Colm “C.J.” Driscoll

Chief Financial Officer

Colm “C.J.” Driscoll has been working in the toxicology industry since 2011 and joined Precision in 2016 as Operations Manager. Initially focused on cost-saving opportunities in the lab, C.J. quickly took on additional responsibilities including revenue recognition and financial modeling which led to his being promoted to Vice President of Finance in late 2017. In that role, he assumed the lead role in Precision’s pursuit of acquisition targets, drawing on his experience as a Manager in KPMG LLP’s Financial Due Diligence group.

As Chief Financial Officer, C.J. works closely with all the company’s departments fostering an environment of collaboration and organization-wide alignment toward obtainment of sustainably profitable growth.

C.J. earned his B.A. in Accounting from Seattle University. Outside of work, he spends most of his time lovingly and dutifully providing personal chef and chauffeur services for his three young children.